The largest database of trusted experimental protocols

1100 plate reader

Manufactured by Tecan

The 1100 Plate Reader is a laboratory instrument designed for absorbance-based measurements in microplates. It is capable of performing spectrophotometric analysis across a wide range of wavelengths, enabling various applications in life science research and clinical diagnostics.

Automatically generated - may contain errors

3 protocols using 1100 plate reader

1

Synergistic Drug Combination Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at the densities grown as stated above. Drug combinations used included enzalutamide plus saracatinib and docetaxel plus saracatinib at their respective IC50 dosages for each cell line. Therapy was given, beginning at 2x the IC50 dose, then serial diluted by 2 till 9 dilution groups were established. Cell viability was measured using WST-1 at 1:10 dilution with CSS-FBS media at absorbance of 450 nm (Tecan 1100 Plate Reader). Measured absorbance was converted in percentile and inputted in the Bliss Independence equation (24 (link)) as well as CompuSyn 1.1, a computer software that determines synergy via Combination Index (25 (link)) between drugs based on individual dose response. Bliss independence is calculated as Fab=Fa x Fb, where Fa/b is the fraction of cells affected by drug A/B and Fab is the product of the two fractions, representing the predicted additivity of the two drugs. Bliss independence value is portrayed with Fab and the experimental values of each combination. Combinations with values greater than Fab are considered synergistic, while combination with values less than Fab are considered antagonistic. Each data point was conducted in technical triplicate.
+ Open protocol
+ Expand
2

Methotrexate Combination Therapy for PC-3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC-3 cells were seeded at 1,400 cells/100 μL in 96-well plates in RPMI media (Sigma-Aldrich) with 10% fetal bovine serum (FBS), 1% penicillin-streptomycin (Pen/Strep), and 1% GlutaGro (Corning). After an overnight incubation at 37°C and 5% CO2, media in the wells were replaced with fresh RPMI media with 5% charcoal-stripped serum (CSS)-FBS, 1% Pen/Strep, and 1% GlutaGro (Corning). Cells were then grown for 3 days. We then added one of the following three drug groups: 50 nM methotrexate alone, 50 nM methotrexate + CPG2CP-N89-K177A (100 to 5,000 pM), or 50 nM methotrexate + Pro-CPG2-1-Disulfide (100 to 5,000 pM). Treatment lasted for 6 days with replenishment of the media, drug, and enzymes after 3 days. Cell viability was measured using WST-1 at 1:10 dilution with CSS-FBS media at absorbance of 450 nm (Tecan 1100 Plate Reader).
+ Open protocol
+ Expand
3

Cell Viability Screening for Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at the following densities: DU-145 (500 cells/0.1 mL), AD1 (2,000 cells/0.1 mL), R1D567 (1,000 cells/0.1 mL), LNCaP95 (4,000 cells/0.1 mL), 22Rv1 (2,000 cells/0.1 mL) in 96 well plates in RPMI media (Sigma-Aldrich) with 10% FBS, 1% penicillin-streptomycin, and 1% Glutamax (Corning). After an overnight incubation at 37°C and 5% CO2, media in the wells was replaced with fresh RPMI media with 5% charcoal-stripped (CSS)-FBS, 1% penicillin-streptomycin, and 1% Glutamax (Corning). Cells were then grown in the media for 3 days. One of the following three drug groups is then administered: enzalutamide, saracatinib, ranging from 0.39-100μM, and docetaxel 0.04-10nM. All drugs were obtained from Selleckchem. Treatment lasted for 6 days with replenishment of the media and drug after 3 days. Cell viability was measured using WST-1 at 1:10 dilution with CSS-FBS media at absorbance of 450 nm (Tecan 1100 Plate Reader). IC50 dosage was calculated using GraphPad Prism. Each data point was conducted in technical and biological triplicate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!